From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

The concept of adaptive licensing (AL) has met with considerable interest. Yet some remain skeptical about its feasibility. Others argue that the focus and name of AL should be broadened. Against this background of ongoing debate, we examine the environmental changes that will likely make adaptive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, H‐G, Baird, LG, Barker, R, Bloechl‐Daum, B, Børlum‐Kristensen, F, Brown, J, Chua, R, Del Signore, S, Dugan, U, Ferguson, J, Garner, S, Goettsch, W, Haigh, J, Honig, P, Hoos, A, Huckle, P, Kondo, T, Le Cam, Y, Leufkens, H, Lim, R, Longson, C, Lumpkin, M, Maraganore, J, O'Rourke, B, Oye, K, Pezalla, E, Pignatti, F, Raine, J, Rasi, G, Salmonson, T, Samaha, D, Schneeweiss, S, Siviero, PD, Skinner, M, Teagarden, JR, Tominaga, T, Trusheim, MR, Tunis, S, Unger, TF, Vamvakas, S, Hirsch, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
State of the Art
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706805/
https://www.ncbi.nlm.nih.gov/pubmed/25669457
http://dx.doi.org/10.1002/cpt.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706805/
https://www.ncbi.nlm.nih.gov/pubmed/25669457
http://dx.doi.org/10.1002/cpt.59

Ejemplares similares